Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 31 to 40 of 2550

TitleReference numberPublishedLast updated
Pegzilarginase for treating arginase-1 deficiency in people 2 years and overHST35
Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancerTA1138
Rare diseasesQS214
Hypertension in adults: diagnosis and managementNG136
Blood transfusionNG24
Blood transfusionQS138
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19TA878
Molnupiravir for treating COVID-19TA1056
Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy for metastatic colorectal cancerTA1136
Canagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)TA1137

Results per page

  1. 10
  2. 25
  3. 50
  4. All